Changchun B. Deng

Oncology

11100 Euclid Ave
Cleveland, OH 44106

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Emerging first-line treatment approaches for mantle cell lymphoma.

Emerging first-line treatment approaches for mantle cell lymphoma.

Journal: Leukemia & lymphoma

Published: November 17, 2025

Twice the trouble, half the fun: twin study suggests future direction for young adults with Hodgkin lymphoma.

Twice the trouble, half the fun: twin study suggests future direction for young adults with Hodgkin lymphoma.

Journal: Leukemia & lymphoma

Published: March 14, 2025

NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.

NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: November 13, 2024

Development and initial results of 320 GHz interferometer system in Heliotron J.

Development and initial results of 320 GHz interferometer system in Heliotron J.

Journal: The Review of scientific instruments

Published: December 03, 2022

Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity.

Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity.

Journal: Blood advances

Published: December 15, 2021

Development of beam emission spectroscopy in the helically symmetric experiment stellarator.

Development of beam emission spectroscopy in the helically symmetric experiment stellarator.

Journal: The Review of scientific instruments

Published: July 10, 2021

Development of a multi-channel 320 GHz interferometer for high density plasma measurement in Heliotron J.

Development of a multi-channel 320 GHz interferometer for high density plasma measurement in Heliotron J.

Journal: The Review of scientific instruments

Published: July 10, 2021

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma.

Journal: Experimental hematology & oncology

Published: October 05, 2020

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study.

Journal: Blood

Published: September 04, 2020

Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience.

Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience.

Journal: Leukemia & lymphoma

Published: July 29, 2020

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.

Journal: Molecular cancer therapeutics

Published: May 06, 2020

ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest.

ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest.

Journal: Oncotarget

Published: March 14, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026